Beyond air, inc.XAIR.US Overview

US StockHealthcare
(No presentation for XAIR)

XAIR Overall Performance

METRIC
VALUE
vs. INDUSTRY
EPS
-8.06
PE Ratio
-
Forward PE
-
PS Ratio
2.43
PB Ratio
1.12
Price-to-FCF
-
Gross Margin
-24.57%
Net Margin
-880.70%
Revenue Growth (YoY)
168.20%
Profit Growth (YoY)
15.83%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
-100.00%

XAIR AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

XAIR Current Performance

-

Beyond air, inc.

0.13%

Avg of Sector

-0.69%

S&P500

XAIR Key Information

XAIR Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2025Q1
2025Q2
2025Q3
2025Q4
2026Q1

XAIR Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2024Q4
2024Q3
2024Q2
2024Q1

XAIR Profile

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Price of XAIR

XAIR FAQ

  • When is XAIR's latest earnings report released?

    The most recent financial report for Beyond air, inc. (XAIR) covers the period of 2026Q1 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating XAIR's short-term business performance and financial health. For the latest updates on XAIR's earnings releases, visit this page regularly.

  • What is the operating profit of XAIR?

    According to the latest financial report, Beyond air, inc. (XAIR) reported an Operating Profit of -7.62M with an Operating Margin of -432.78% this period, representing a growth of 43.91% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is XAIR's revenue growth?

    In the latest financial report, Beyond air, inc. (XAIR) announced revenue of 1.76M, with a Year-Over-Year growth rate of 157.69%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does XAIR have?

    As of the end of the reporting period, Beyond air, inc. (XAIR) had total debt of 11.69M, with a debt ratio of 0.42. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does XAIR have?

    At the end of the period, Beyond air, inc. (XAIR) held Total Cash and Cash Equivalents of 5.14M, accounting for 0.18 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does XAIR go with three margins increasing?

    In the latest report, Beyond air, inc. (XAIR) did not achieve the “three margins increasing” benchmark, with a gross margin of 8.9%%, operating margin of -432.78%%, and net margin of -437%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess XAIR's profit trajectory and future growth potential.

  • Is XAIR's EPS continuing to grow?

    According to the past four quarterly reports, Beyond air, inc. (XAIR)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -1.53. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of XAIR?

    Beyond air, inc. (XAIR)'s Free Cash Flow (FCF) for the period is -4.72M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 63.25% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of XAIR?

    The latest valuation data shows Beyond air, inc. (XAIR) has a Price-To-Earnings (PE) ratio of -0.39 and a Price/Earnings-To-Growth (PEG) ratio of 0.04. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.